Insider Transactions in Q1 2022 at Galectin Therapeutics Inc (GALT)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,870
+2.31%
|
$10,870
$1.61 P/Share
|
|
Mar 15
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,057
+2.2%
|
$10,057
$1.74 P/Share
|
|
Feb 28
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,358
+95.54%
|
$9,358
$1.87 P/Share
|
|
Feb 15
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
8,454
+1.93%
|
$16,908
$2.07 P/Share
|
|
Feb 02
2022
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$20,000
$2.1 P/Share
|
|
Jan 31
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
112,263
+21.09%
|
$112,263
$1.93 P/Share
|
|
Jan 24
2022
|
Richard E Uihlein |
BUY
Grant, award, or other acquisition
|
Direct |
17,677
+0.22%
|
$17,677
$1.98 P/Share
|
|
Jan 21
2022
|
Elissa J. Schwartz |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$2,000
$2.0 P/Share
|
|
Jan 19
2022
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Indirect |
5,000
+9.09%
|
$5,000
$1.96 P/Share
|
|
Jan 14
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
8,251
+2.61%
|
$16,502
$2.02 P/Share
|
|
Jan 14
2022
|
Richard A. Zordani Jr. |
BUY
Open market or private purchase
|
Direct |
5,000
+20.34%
|
$10,000
$2.02 P/Share
|
|
Jan 11
2022
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$20,000
$2.1 P/Share
|